Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant TNF alpha (Infliximab Biosimilar) anticorps

Reactivité: Humain FACS, in vivo Hôte: Souris Monoclonal cA2 unconjugated Recombinant Antibody
N° du produit ABIN7200661
  • Antigène Tous les produits TNF alpha (Infliximab Biosimilar)
    TNF alpha (Infliximab Biosimilar)
    Type d'anticorp
    Recombinant Antibody
    Reactivité
    Humain
    Hôte
    • 1
    • 1
    • 1
    Souris
    Clonalité
    • 3
    Monoclonal
    Conjugué
    • 3
    Cet anticorp TNF alpha (Infliximab Biosimilar) est non-conjugé
    Application
    • 3
    • 2
    • 2
    • 1
    Flow Cytometry (FACS), In vivo Studies (in vivo)
    Fonction
    Infliximab Biosimilar, TNF alpha Monoclonal Antibody
    Specificité
    The monoclonal antibody Infliximab biosimilar specifically binds to the human TNF alpha.
    Attributs du produit
    Recombinant Chimeric IgG1 Monoclonal Antibody.
    Purification
    Protein A affinity column
    Pureté
    > 95% by SDS-PAGE under reducing conditions and HPLC.
    Stérilité
    0.2 μm filtered
    niveau d'endotoxine
    < 1 EU per 1 mg of the protein by the LAL method.
    Immunogène
    The monoclonal antibody Infliximab biosimilar was produced in the Infliximab biosimilar CHO stable cell line.
    Clone
    CA2
    Isotype
    IgG1 kappa
  • Indications d'application
    ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Infliximab.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 mg/mL
    Buffer
    PBS, pH 7.4, no stabilizers or preservatives.
    Agent conservateur
    Without preservative
    Conseil sur la manipulation
    Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
    Date de péremption
    12 months
  • Antigène
    TNF alpha (Infliximab Biosimilar)
    Abstract
    TNF alpha (Infliximab Biosimilar) Produits
    Synonymes
    anticorps DIF, anticorps TNF-alpha, anticorps TNFA, anticorps TNFSF2, anticorps tumor necrosis factor, anticorps TNF
    Classe de substances
    Biosimilar
    Sujet
    Infliximab, a chimeric anti-TNF-α monoclonal antibody, is used to treat psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Infliximab interferes TNF-α from binding to its receptor in the cell.

    Mainly produced by activated macrophages (M1), Tumor necrosis factor (TNF, cachexin, cachectin, tumor necrosis factor alpha, TNFα) plays important roles in the regulation of autoimmune reaction.
Vous êtes ici:
Support technique